Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Non-cash Items (2020 - 2022)

Historic Non-cash Items for Caribou Biosciences (CRBU) over the last 3 years, with Q2 2022 value amounting to $31.5 million.

  • Caribou Biosciences' Non-cash Items rose 50354.47% to $31.5 million in Q2 2022 from the same period last year, while for Jun 2022 it was $31.5 million, marking a year-over-year increase of 50354.47%. This contributed to the annual value of $50.1 million for FY2021, which is 62283.16% up from last year.
  • Per Caribou Biosciences' latest filing, its Non-cash Items stood at $31.5 million for Q2 2022, which was up 50354.47% from $1.6 million recorded in Q1 2022.
  • In the past 5 years, Caribou Biosciences' Non-cash Items ranged from a high of $50.1 million in Q4 2021 and a low of $1.6 million during Q1 2022
  • Over the past 3 years, Caribou Biosciences' median Non-cash Items value was $7.3 million (recorded in 2020), while the average stood at $17.2 million.
  • Per our database at Business Quant, Caribou Biosciences' Non-cash Items soared by 62283.16% in 2021 and then soared by 50354.47% in 2022.
  • Quarter analysis of 3 years shows Caribou Biosciences' Non-cash Items stood at $6.9 million in 2020, then surged by 622.83% to $50.1 million in 2021, then plummeted by 37.11% to $31.5 million in 2022.
  • Its Non-cash Items was $31.5 million in Q2 2022, compared to $1.6 million in Q1 2022 and $50.1 million in Q4 2021.